<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en-US" data-colors-preset="contrast" data-primary-color="#307FFF"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="UTF-8">  <meta name="built-on" content="2024-01-01T13:06:23.9596514"><meta name="build-number" content="${buildNumber}">       <title>华东医药：子公司与韩国ATGC公司签订含有A型肉毒杆菌毒素的注射液ATGC-110独家许可协议 | 2023-10-17</title><script id="virtual-toc-data" type="application/json">[]</script><script id="topic-shortcuts" type="application/json"></script><link href="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.css" rel="stylesheet">   <link rel="apple-touch-icon" sizes="180x180" href="https://jetbrains.com/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="https://jetbrains.com/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="https://jetbrains.com/favicon-16x16.png"><link rel="manifest" href="https://jetbrains.com/site.webmanifest"><link rel="mask-icon" href="https://jetbrains.com/safari-pinned-tab.svg" color="#000000"><meta name="msapplication-TileColor" content="#000000"/><meta name="msapplication-TileImage" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-144x144.png"/><meta name="msapplication-square70x70logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-70x70.png"/><meta name="msapplication-square150x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-150x150.png"/><meta name="msapplication-wide310x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x150.png"/><meta name="msapplication-square310x310logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x310.png"/>  <meta name="image" content=""><!-- Open Graph --><meta property="og:title" content="华东医药：子公司与韩国ATGC公司签订含有A型肉毒杆菌毒素的注射液ATGC-110独家许可协议 | 2023-10-17"/><meta property="og:description" content=""/><meta property="og:image" content=""/><meta property="og:site_name" content="2023-10-17 Help"/><meta property="og:type" content="website"/><meta property="og:locale" content="en_US"/><meta property="og:url" content="5421.html"/><!-- End Open Graph --><!-- Twitter Card --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content=""><meta name="twitter:title" content="华东医药：子公司与韩国ATGC公司签订含有A型肉毒杆菌毒素的注射液ATGC-110独家许可协议 | 2023-10-17"><meta name="twitter:description" content=""><meta name="twitter:creator" content=""><meta name="twitter:image:src" content=""><!-- End Twitter Card --><!-- Schema.org WebPage --><script type="application/ld+json"> { "@context": "http://schema.org", "@type": "WebPage", "@id": "5421.html#webpage", "url": "5421.html", "name": "华东医药：子公司与韩国ATGC公司签订含有A型肉毒杆菌毒素的注射液ATGC-110独家许可协议 | 2023-10-17", "description": "", "image": "", "inLanguage":"en-US" }</script><!-- End Schema.org --><!-- Schema.org WebSite --><script type="application/ld+json"> { "@type": "WebSite", "@id": "/#website", "url": "/", "name": "2023-10-17 Help" }</script><!-- End Schema.org --></head>      <body data-id="5421" data-main-title="华东医药：子公司与韩国ATGC公司签订含有A型肉毒杆菌毒素的注射液ATGC-110独家许可协议" data-article-props="{&quot;seeAlsoStyle&quot;:&quot;links&quot;}"  data-template="article"  data-breadcrumbs=""  >   <div class="wrapper"><main class="panel _main"><header class="panel__header"><div class="container"><h3>2023-10-17  Help</h3><div class="panel-trigger"></div></div></header><section class="panel__content"><div class="container"><article class="article" data-shortcut-switcher="inactive"><h1 data-toc="5421"   id="5421.md">华东医药：子公司与韩国ATGC公司签订含有A型肉毒杆菌毒素的注射液ATGC-110独家许可协议</h1>  <p id="f51236ac_34"><span class="control" id="f51236ac_35">界面快报</span></p><p id="f51236ac_36"><span class="control" id="f51236ac_37">2023-10-17 09:13</span></p><p id="f51236ac_38"><span class="control" id="f51236ac_39">https://www.jiemian.com/article/10240834.html</span></p><p id="f51236ac_40">华东医药10月17日公告，10月17日，公司全资子公司Huadong Medicine Aesthetics Investment (Hong Kong) Limited（华东医药医美投资（香港）有限公司，以下简称&ldquo;医美投资&rdquo;）与韩国ATGCCo.,Ltd.（以下简称&ldquo;ATGC&rdquo;）签订了产品独家许可协议。</p><p id="f51236ac_41">医美投资获得ATGC拥有的含有A型肉毒杆菌毒素的注射液ATGC-110在包括中国、美国、欧洲等区域在内的全球独家许可（不含印度），以及在韩国的非独家许可，包含医美及治疗的所有适应症的临床开发、注册及商业化权益。医美投资将向ATGC支付1300万美元首付款，最高不超过1700万美元的临床开发、注册里程碑。</p><p id="f51236ac_42">ATGC-110系一种基于ATGC自主开发的、处于临床研究阶段的神经调节物，其药物活性成分为150kDaA型肉毒素，用于改善成年患者的中度至重度眉间纹。</p><div class="last-modified"> Last modified: 01 一月 2024</div><div data-feedback-placeholder="true"></div><div class="navigation-links _bottom">  <a class="navigation-links__prev" href="5422.html">四维图新：第一大股东已由中国四维变更为屹唐新程</a>   <a class="navigation-links__next" href="5420.html">四川崇州再通报&ldquo;女童在小区遭恶犬围咬&rdquo;：狗主人被采取刑事强制措施</a>  </div></article><div id="disqus_thread"></div></div></section></main></div>  <script src="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.js"></script></body></html>